{"id":"https://openalex.org/W7204784801","doi":"https://doi.org/10.5281/zenodo.22207792","title":"Prospective Causal Forecast and Resistance-Attribution Framework for Neogene-Specific TCR-T Therapy in Ewing Sarcoma","display_name":"Prospective Causal Forecast and Resistance-Attribution Framework for Neogene-Specific TCR-T Therapy in Ewing Sarcoma","publication_year":2026,"publication_date":"2026-08-31","ids":{"openalex":"https://openalex.org/W7204784801","doi":"https://doi.org/10.5281/zenodo.22207792"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.22207792","doi":"https://doi.org/10.5281/zenodo.22207792","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.22207792","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Report"},"volume":null,"type":"report","is_traditional":false,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.22207792","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5139046579","display_name":"Mohammed El Amin Bouchelit","orcid":"https://orcid.org/0009-0000-1904-6365","observed_orcids":["https://orcid.org/0009-0000-1904-6365"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Bouchelit, Mohammed El Amin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-1904-6365","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5139046579"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8140000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8140000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.11050000041723251,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.022600000724196434,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.9490000009536743},{"id":"https://openalex.org/keywords/ewsr1-fli1-fusion","display_name":"EWSR1-FLI1 fusion","score":0.8100000023841858},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.5049999952316284},{"id":"https://openalex.org/keywords/mhc-peptide-presentation","display_name":"MHC-peptide presentation","score":0.7129999995231628},{"id":"https://openalex.org/keywords/causal-modeling","display_name":"causal models","score":0.3880000114440918},{"id":"https://openalex.org/keywords/preclinical-evidence","display_name":"preclinical evidence","score":0.42500001192092896},{"id":"https://openalex.org/keywords/scoring-rules","display_name":"scoring rules","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C71745522","wikidata":"https://www.wikidata.org/wiki/Q2476929","display_name":"Confidentiality","level":2,"score":0.5453000068664551},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4693000018596649},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45750001072883606},{"id":"https://openalex.org/C83009810","wikidata":"https://www.wikidata.org/wiki/Q11204","display_name":"Legislature","level":2,"score":0.42829999327659607},{"id":"https://openalex.org/C512654426","wikidata":"https://www.wikidata.org/wiki/Q19652","display_name":"Public domain","level":2,"score":0.376800000667572},{"id":"https://openalex.org/C2781426162","wikidata":"https://www.wikidata.org/wiki/Q2275793","display_name":"Casual","level":2,"score":0.36980000138282776},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.36820000410079956},{"id":"https://openalex.org/C204434341","wikidata":"https://www.wikidata.org/wiki/Q357789","display_name":"Adjudication","level":2,"score":0.36500000953674316},{"id":"https://openalex.org/C2777601897","wikidata":"https://www.wikidata.org/wiki/Q3409113","display_name":"Presentation (obstetrics)","level":2,"score":0.30550000071525574},{"id":"https://openalex.org/C2777026412","wikidata":"https://www.wikidata.org/wiki/Q2684591","display_name":"Statement (logic)","level":2,"score":0.304500013589859},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.29019999504089355},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.28929999470710754},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.28679999709129333},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.2784000039100647},{"id":"https://openalex.org/C2777586341","wikidata":"https://www.wikidata.org/wiki/Q1138580","display_name":"Ewing's sarcoma","level":3,"score":0.2721000015735626},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.2712000012397766},{"id":"https://openalex.org/C68122502","wikidata":"https://www.wikidata.org/wiki/Q764527","display_name":"Informed consent","level":3,"score":0.26840001344680786},{"id":"https://openalex.org/C158154518","wikidata":"https://www.wikidata.org/wiki/Q7310970","display_name":"Relevance (law)","level":2,"score":0.26019999384880066},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.25870001316070557}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.22207792","doi":"https://doi.org/10.5281/zenodo.22207792","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.22207792","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Report"},{"id":"doi:10.5281/zenodo.22207793","doi":"https://doi.org/10.5281/zenodo.22207793","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.22207793","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Report"}],"best_oa_location":{"id":"doi:10.5281/zenodo.22207792","doi":"https://doi.org/10.5281/zenodo.22207792","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.22207792","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Report"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7166079608","https://openalex.org/W7204253996","https://openalex.org/W1980571131","https://openalex.org/W2520073560","https://openalex.org/W4413398045","https://openalex.org/W2149778351","https://openalex.org/W6991435204","https://openalex.org/W2404892030","https://openalex.org/W2079166902","https://openalex.org/W7139547809"],"abstract_inverted_index":{"Prospective":[0,21,27,335,1159],"Causal":[1],"Forecast":[2],"and":[3,136,206,210,282,287,371,395,459,481,521,572,581,589,593,623,634,652,672,685,725,754,763,824,875,941,1027,1035,1062,1068,1086,1146,1194,1211,1285],"Resistance-Attribution":[4],"Frameworkfor":[5],"Neogene-Specific":[6],"TCR-T":[7,208,231,583,731,748,889,990,1073,1093,1169],"Therapy":[8],"in":[9,84,212,346,369,529,598,602,664,668,688,851,859,896,1154,1179,1241],"Ewing":[10,213,504,525,569,665,897],"Sarcoma":[11],"A":[12,300,553],"pre-specified":[13],"HISTAMOS":[14,20,40,79,96,473,864,1124],"analysis":[15,28,74,165,293],"before":[16,88],"THEODORA":[17,60,110,149,215,465,704,787,1140],"clinical":[18,61,252,333,362,457,494,617,945,1212],"readout":[19],"Adjudication":[22],"P1":[23,1164],"(R0)":[24],"Document":[25],"type:":[26],"/":[29,928,1162],"preregistered":[30],"forecast":[31],"|":[32],"Evidence":[33],"cutoff:":[34],"30":[35],"August":[36],"2026":[37,554],"Institutional":[38],"author":[39],"Independent":[41],"Research":[42],"Correspondence":[43],"contact@histamos.com":[44],"\u2013":[45],"www.histamos.com":[46],"Version":[47],"R0":[48,94,180],"\u2014":[49,959,993,1016,1043,1082,1165,1207,1258],"prospective":[50,450,516,1108,1118],"freeze":[51],"candidate":[52],"for":[53,1200,1237,1248],"public":[54,86,297,522,767,1133],"deposition":[55],"Clinical":[56],"authority":[57,939],"None.":[58],"No":[59,158,947,960],"outcome":[62],"data":[63,878],"are":[64,399,563,926,1089,1113,1122,1136,1142,1147],"used":[65,308,759],"or":[66,105,112,128,133,145,150,176,268,332,430,492,626,801,841,872,894,917,944,966,978,1012,1052,1099,1280],"claimed.":[67],"INDEPENDENT":[68],"PROVENANCE":[69],"AND":[70],"RELATIONSHIP":[71],"STATEMENT":[72],"This":[73,445,606,1075],"was":[75,586],"conducted":[76],"independently":[77,1071],"by":[78,532,560,576,712,970],"using":[80],"only":[81,940],"information":[82],"available":[83,850,901],"the":[85,89,169,184,244,313,319,405,594,794,900,1078,1100,1116,1131,1150],"domain":[87],"evidence":[90,194,298,523,902],"cutoff.":[91],"Before":[92],"this":[93,116,156,164,172,187,781,831],"freeze,":[95],"had":[97,118,137],"no":[98,119,138],"scientific":[99],"discussion,":[100],"consultation,":[101],"feedback,":[102],"protocol":[103,845],"review,":[104],"other":[106,146,979],"substantive":[107],"communication":[108],"with":[109,148,227,431,500,597,682,1058],"investigators":[111],"participating":[113,152],"institutions":[114,153],"concerning":[115],"analysis;":[117],"access":[120],"to":[121,155,163,203,221,260,310,342,356,366,382,470,487,645,649,760,835,842,857,986,1023,1149,1173,1185],"unpublished":[122,464],"results,":[123],"non-public":[124],"protocols,":[125],"internal":[126,303],"biomarker":[127],"monitoring":[129],"plans,":[130],"confidential":[131],"correspondence,":[132],"patient-level":[134,948],"data;":[135],"contractual,":[139],"advisory,":[140],"employment,":[141],"collaborative,":[142],"financial,":[143],"licensing,":[144],"relationship":[147,177],"its":[151,235],"relevant":[154,162],"work.":[157],"conflict":[159],"of":[160,171,186,351,387,404,455,463,721,830,905,910,1010,1130],"interest":[161],"is":[166,216,241,247,294,307,327,379,426,447,469,527,621,661,710,799,833,847,855,951,968,998,1170,1232,1261],"declared":[167],"at":[168,347,550,1180,1242],"time":[170],"release.":[173],"Any":[174],"contact":[175],"established":[178],"after":[179,1066],"does":[181,613,783],"not":[182,242,328,380,427,452,460,614,770,784,834,848,1137,1143,1262,1274],"alter":[183],"provenance":[185],"frozen":[188,1114],"record.":[189,1119],"Abstract":[190],"Background:":[191],"Public":[192,738],"preclinical":[193,603],"supports":[195],"a":[196,217,228,280,349,384,415,432,448,453,461,479,489,608,698,728,734,790,844,987,1054,1182,1222,1263],"mechanistic":[197],"chain":[198,611],"from":[199,908,1127,1139],"EWSR1::FLI1-driven":[200],"neogene":[201,377,406,1270],"expression":[202,655,660],"HLA-I":[204,566,587,659,680],"presentation":[205,1039,1284],"neogene-specific":[207,577,888],"recognition":[209],"killing":[211],"sarcoma.":[214],"European":[218,735],"program":[219,498],"scheduled":[220],"begin":[222],"on":[223,296,391,565,568,591],"1":[224,722],"September":[225,723],"2026,":[226,724],"first-in-child":[229,729],"neogene-targeted":[230,730],"substudy":[232,732],"planned":[233],"within":[234,733],"master-protocol":[236,736],"framework.":[237,737],"The":[238,292,828,853,882,931,1110],"unresolved":[239],"question":[240,825,885],"whether":[243,251,312,772],"target":[245,501],"concept":[246],"biologically":[248],"plausible,":[249,867],"but":[250,612,1001,1092],"resistance,":[253,392],"if":[254,364,796,887,1037,1214],"it":[255,326],"occurs,":[256],"can":[257,317,573,629,899],"be":[258,367,383,485,574,758,777,1217],"localized":[259],"antigen":[261,510,906],"source,":[262],"cognate":[263,424,774,911,1002,1025,1087],"peptide\u2013MHC":[264],"presentation,":[265,913],"tumor":[266,512,675,751,983,1056,1101,1239],"state,":[267],"downstream":[269,396,918,1038],"immune":[270,397,701,746],"execution.":[271],"Methods:":[272],"We":[273,337,360],"prospectively":[274],"specify":[275,858],"five":[276],"competing":[277,955],"causal":[278,321,862,956,1128],"models,":[279],"qualitative":[281],"probabilistic":[283],"forecast,":[284],"decisive":[285],"measurements,":[286],"explicit":[288],"future":[289,490,877],"scoring":[290,1152],"rules.":[291],"based":[295],"only.":[299],"previously":[301],"completed":[302],"synthetic":[304,932],"design-qualification":[305],"exercise":[306],"solely":[309],"assess":[311],"proposed":[314],"measurement":[315],"architecture":[316],"distinguish":[318,903],"prespecified":[320],"worlds":[322],"under":[323,826],"simulated":[324],"conditions;":[325],"treated":[329,353],"as":[330,478,1115],"biological":[331,344,610,943,1176,1204],"evidence.":[334,1080],"forecast:":[336],"assign":[338],"higher":[339],"prior":[340,1198,1236,1247],"probability":[341,1199],"demonstrable":[343],"activity":[345,549,600,620,1178],"least":[348,1181,1243],"subset":[350,1183],"appropriately":[352],"patients":[354,1231],"than":[355,1184],"complete":[357,402,1187],"target-concept":[358,1188],"failure.":[359,502,1014],"expect":[361],"activity,":[363,1213],"present,":[365],"heterogeneous":[368,493,622,892,1218],"depth":[370],"durability.":[372],"Baseline":[373,1259],"HLA":[374,1267],"match":[375,1268],"plus":[376,1269],"presence":[378,1271],"expected":[381],"sufficient":[385,1264],"selector":[386,1266],"durable":[388,409,616,961,1055,1104,1226,1251,1281],"response.":[389,1282],"Conditional":[390],"source/presentation/visibility":[393],"failure":[394,499],"execution":[398,1286],"prioritized":[400],"over":[401],"invalidity":[403],"concept,":[407],"while":[408],"TCR-selected":[410,1044],"coupled":[411,914,1045,1059],"state":[412,692,740,1057,1287],"escape":[413],"remains":[414,984,1040],"higher-evidence":[416],"claim":[417,785,1158],"that":[418,557,741,786,797,846,1064],"requires":[419,1077],"direct":[420],"demonstration.":[421],"If":[422],"exact":[423,773],"pMHC":[425,775,809,912,1003,1026,1034,1088],"measured":[428,778],"directly":[429],"sufficiently":[433,1022,1090],"proximal":[434],"validated":[435],"surrogate,":[436],"some":[437,1201,1244],"resistance":[438,514,764,1063],"states":[439,633],"may":[440,879],"remain":[441,880],"attributionally":[442],"unresolved.":[443],"Conclusion:":[444],"document":[446],"falsifiable":[449],"record,":[451],"prediction":[454],"broad":[456],"success":[458],"critique":[462],"design.":[466],"Its":[467],"purpose":[468],"pre-specify":[471],"what":[472,475,482],"expects,":[474],"would":[476,484,870],"count":[477],"miss,":[480],"measurements":[483],"required":[486],"interpret":[488],"negative":[491],"result":[495],"without":[496],"conflating":[497],"Keywords:":[503],"sarcoma;":[505],"EWSR1::FLI1;":[506],"neogene;":[507],"TCR-T;":[508],"peptide\u2013MHC;":[509],"presentation;":[511],"plasticity;":[513],"attribution;":[515],"forecast;":[517],"THEODORA.":[518],"1.":[519],"Rationale":[520],"boundary":[524],"sarcoma":[526,570],"driven":[528],"most":[530,536,866,1229,1254],"cases":[531],"an":[533,689,716,837],"EWSR1::ETS":[534],"fusion,":[535],"commonly":[537],"EWSR1::FLI1.":[538],"Recent":[539],"work":[540],"has":[541,715,937],"identified":[542],"EWSR1::FLI1-induced":[543],"neogenes":[544,562],"generated":[545],"through":[546],"neomorphic":[547],"transcriptional":[548,636],"GGAA":[551],"microsatellites.":[552],"preprint":[555],"reported":[556,601,644],"peptides":[558],"encoded":[559],"these":[561],"presented":[564],"complexes":[567],"cells":[571,580,640],"recognized":[575],"CD8":[578],"T":[579],"engineered":[582],"cells.":[584],"Killing":[585],"restricted":[588],"dependent":[590],"EWSR1::FLI1":[592,619],"corresponding":[595],"neogene,":[596],"vivo":[599],"models":[604,957],"[1].":[605],"establishes":[607],"credible":[609],"establish":[615,771],"control.":[618],"dynamic;":[624],"graded":[625],"transient":[627,971],"reductions":[628],"produce":[630],"distinct":[631],"phenotypic":[632],"persistent":[635],"consequences":[637],"[2,3].":[638],"EWS-FLI1-low":[639],"have":[641,677],"also":[642],"been":[643],"show":[646,1174,1186],"reduced":[647,663],"susceptibility":[648],"T-cell-mediated":[650],"apoptosis":[651],"increased":[653],"PD-L1/PD-L2":[654],"[4].":[656],"In":[657],"parallel,":[658],"frequently":[662],"sarcoma,":[666,898],"especially":[667],"advanced":[669],"disease":[670],"[5],":[671],"paired":[673],"human":[674],"analyses":[676],"implicated":[678],"low":[679],"together":[681],"altered":[683],"IFN":[684],"TGF-beta":[686],"signaling":[687],"immunologically":[690],"resistant":[691],"[6].":[693],"Single-cell":[694],"studies":[695],"further":[696],"support":[697,871],"functionally":[699],"impaired":[700],"microenvironment":[702,1102],"[7].":[703],"(Horizon":[705],"Europe":[706],"Grant":[707],"Agreement":[708],"101288100)":[709],"coordinated":[711],"Institut":[713],"Curie,":[714],"official":[717],"project":[718],"start":[719],"date":[720],"publicly":[726,849],"describes":[727],"descriptions":[739,768],"liquid":[742],"biopsy,":[743],"AI-enhanced":[744],"imaging,":[745],"profiling,":[747],"monitoring,":[749],"circulating":[750],"DNA":[752],"analysis,":[753],"statistical":[755],"modelling":[756],"will":[757,776,1216,1273,1288],"track":[761],"response":[762,839,893,1227],"[8,9].":[765],"These":[766],"do":[769],"directly;":[779],"therefore":[780],"paper":[782],"lacks":[788],"such":[789],"measurement.":[791],"It":[792],"identifies":[793],"consequence":[795],"layer":[798],"absent":[800],"insufficiently":[802],"resolved.":[803],"ANTIGEN":[804],"SOURCE":[805],"\u2260":[806,810,817],"EXACT":[807],"COGNATE":[808],"PRODUCTIVE":[811],"TCR":[812,1007,1028,1049,1278],"VISIBILITY":[813],"INITIAL":[814],"TREATMENT":[815],"FAILURE":[816],"DURABLE":[818],"TUMOR-INTRINSIC":[819],"RESISTANCE":[820],"2.":[821],"Scope,":[822],"authority,":[823],"adjudication":[827,884],"object":[829,854],"preregistration":[832],"predict":[836],"overall":[838],"rate":[840],"judge":[843],"full.":[852],"narrower:":[856],"advance":[860],"which":[861,868,876],"structures":[863],"considers":[865],"observations":[869],"refute":[873],"them,":[874],"non-identifying.":[881],"primary":[883,1117],"is:":[886],"treatment":[890,949],"produces":[891],"progression":[895,967],"loss":[904,909,1061],"source":[907,997,1020,1030],"state/visibility":[915],"escape,":[916],"effector":[919,974],"failure?":[920],"Authority":[921],"boundary:":[922],"all":[923],"predictions":[924],"below":[925,1005],"HYPOTHESIS":[927],"PROSPECTIVE":[929],"FORECAST.":[930],"stress":[933],"test":[934],"described":[935],"later":[936],"DESIGN-IDENTIFIABILITY":[938],"zero":[942],"authority.":[946],"recommendation":[950],"made.":[952],"3.":[953],"Prespecified":[954],"M0":[958],"tumor-intrinsic":[962],"escape:":[963,995,1018,1047],"Initial":[964],"non-response":[965],"dominated":[969],"exposure,":[972],"trafficking,":[973,1094],"fitness,":[975],"microenvironmental":[976],"suppression,":[977],"non-persistent":[980],"factors;":[981],"recovered":[982],"susceptible":[985],"fresh":[988,1070],"qualified":[989,1072],"challenge.":[991],"M1":[992],"Presentation-dominant":[994],"Neogene":[996],"substantially":[999],"preserved,":[1000,1091],"falls":[1004,1021],"productive":[1006,1277],"visibility":[1008,1046,1279],"because":[1009],"HLA/antigen-processing":[1011],"presentation-level":[1013],"M2":[1015],"Source-loss-dominant":[1017],"EWSR1::FLI1/neogene":[1019],"reduce":[1024],"recognition;":[1029],"restoration":[1031],"should":[1032],"recover":[1033],"function":[1036],"competent.":[1041],"M3":[1042],"Repeated":[1048],"pressure":[1050],"selects":[1051],"stabilizes":[1053],"source/pMHC":[1060],"persists":[1065],"washout":[1067],"survives":[1069],"rechallenge.":[1074],"model":[1076],"strongest":[1079],"M4":[1081],"Effector/TME-dominant":[1083],"failure:":[1084],"Source":[1085],"persistence,":[1095],"activation,":[1096],"cytotoxic":[1097],"execution,":[1098],"prevents":[1103],"killing.":[1105],"4.":[1106],"Frozen":[1107,1157],"forecasts":[1109],"following":[1111],"claims":[1112],"Probability":[1120],"bands":[1121],"subjective":[1123],"priors":[1125],"derived":[1126],"synthesis":[1129],"cited":[1132],"evidence;":[1134],"they":[1135],"estimated":[1138],"data,":[1141],"population":[1144],"parameters,":[1145],"secondary":[1148],"categorical":[1151],"contract":[1153],"Section":[1155],"5.":[1156],"statement":[1160],"Prior":[1161],"interpretation":[1163],"Biological":[1166,1210],"proof-of-mechanism":[1167],"Neogene-specific":[1168],"more":[1171],"likely":[1172],"interpretable":[1175,1203],"antitumor":[1177],"non-functionality,":[1189],"assuming":[1190],"adequate":[1191],"manufacturing,":[1192],"delivery,":[1193],"T-cell":[1195],"exposure.":[1196],"70\u201385%":[1197],"mechanistically":[1202],"activity.":[1205],"P2":[1206],"Response":[1208],"heterogeneity":[1209],"observed,":[1215],"across":[1219,1228,1253],"eligible":[1220,1230],"patients;":[1221,1245],"consistently":[1223],"high,":[1224],"deep,":[1225,1250],"less":[1233],"likely.":[1234],"45\u201365%":[1235],"objective":[1238],"responses":[1240],"15\u201330%":[1246],"broad,":[1249],"control":[1252],"evaluable":[1255],"patients.":[1256],"P3":[1257],"eligibility":[1260],"durable-response":[1265],"alone":[1272],"fully":[1275],"determine":[1276],"Downstream":[1283],"contain":[1289],"additional":[1290],"decision-relevant":[1291],"information.":[1292],"Qualitat":[1293]},"counts_by_year":[],"updated_date":"2026-10-07T09:51:55.459714","created_date":"2026-09-01T00:00:00"}